Filing Details

Accession Number:
0001104659-21-001123
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-05 19:01:15
Reporting Period:
2020-12-31
Accepted Time:
2021-01-05 19:01:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc. ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1677141 Sandip Kapadia C/o Intercept Pharmaceuticals, Inc.
10 Hudson Yards, Floor 37
New York NY 10001
Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-31 859 $24.70 26,299 No 4 F Direct
Common Stock Disposition 2021-01-01 342 $24.70 25,957 No 4 F Direct
Common Stock Disposition 2021-01-05 2,193 $24.47 23,764 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 S Direct
Footnotes
  1. Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.
  2. Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person.
  3. This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.